The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen.
FOX 9 Minneapolis-St. Paul on MSN3d
Generic prescription drug prices marked up as high as 5,000%, investigation findsA new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...
Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.
Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...
Campbell’s lawsuit follows similar suits in other states and a lawsuit brought by the Federal Trade Commission that aim to ...
The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback